Tissue Robert S

Senior VP & CFOSUMMIT FINANCIAL GROUP, INC. (SMMF) · full profile →Form 4 · filed May 3, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
4 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 3, 2024Other(J)1K$020K
May 3, 2024Disposed to issuer(D)60K0
May 3, 2024Disposed to issuer(D)20K0
May 3, 2024Disposed to issuer(D)7400

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 3, 2024Disposed to issuer(D)17K0
May 3, 2024Disposed to issuer(D)17K0
May 3, 2024Disposed to issuer(D)17K0
May 3, 2024Disposed to issuer(D)8K0
May 3, 2024Disposed to issuer(D)11K0

Transaction Codes

J
Other acquisition / disposition
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-014545) within minutes of acceptance. Every field above traces to the original document. Verify it directly: